| For: | Deibert P, Lazaro A, Schaffner D, Berg A, Koenig D, Kreisel W, Baumstark MW, Steinmann D, Buechert M, Lange T. Comprehensive lifestyle intervention vs soy protein-based meal regimen in non-alcoholic steatohepatitis. World J Gastroenterol 2019; 25(9): 1116-1131 [PMID: 30862999 DOI: 10.3748/wjg.v25.i9.1116] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i9/1116.htm |
| Number | Citing Articles |
| 1 |
Menooa Ebrahimi, Seyed Arsalan Seyedi, Seyed Ali Nabipoorashrafi, Soghra Rabizadeh, Mojdeh Sarzaeim, Amirhossein Yadegar, Fatemeh Mohammadi, Razman Arabzadeh Bahri, Peyman Pakravan, Paria Shafiekhani, Manouchehr Nakhjavani, Alireza Esteghamati. Lipid accumulation product (LAP) index for the diagnosis of nonalcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis. Lipids in Health and Disease 2023; 22(1) doi: 10.1186/s12944-023-01802-6
|
| 2 |
Sayma Yaqub, Patricia Ananias, Arpita Shah, Kanita Luenam, Arunima Mariya Jose, Joao Pedro Melo, Arifa Turkistani, Lubna Mohammed. Decoding the Pathophysiology of Non-alcoholic Fatty Liver Disease Progressing to Non-alcoholic Steatohepatitis: A Systematic Review. Cureus 2021; doi: 10.7759/cureus.18201
|
| 3 |
Margaret Spinosa, She-Yan Wong. Screening for Non-alcoholic Fatty Liver Disease in Current Practice. Current Hepatology Reports 2021; 20(4) doi: 10.1007/s11901-021-00577-7
|
| 4 |
Mathilde Simonson, Yves Boirie, Christelle Guillet. Protein, amino acids and obesity treatment. Reviews in Endocrine and Metabolic Disorders 2020; 21(3) doi: 10.1007/s11154-020-09574-5
|
| 5 |
Scott A. Willis, Stephen J. Bawden, Sundus Malaikah, Jack A. Sargeant, David J. Stensel, Guruprasad P. Aithal, James A. King. The role of hepatic lipid composition in obesity‐related metabolic disease. Liver International 2021; 41(12) doi: 10.1111/liv.15059
|
| 6 |
Ana Raimunda Dâmaso, Flávia Campos Corgosinho, Deborah Cristina Landi Masquio, Nayra Figueiredo, Fabiana Kattah, Cintia Cercato, Lian Tock, Raquel Munhoz da Silveira Campos. Multidisciplinary Therapy to Target Obesity and Its Complications in Adult Population: A Narrative Review. Obesity Reviews 2026; 27(7) doi: 10.1111/obr.70093
|
| 7 |
V. H. Nguyen, Y. H. Yeo, B. Zou, M. H. Le, L. Henry, R. C. Cheung, M. H. Nguyen. Discrepancies between actual weight, weight perception and weight loss intention amongst persons with NAFLD. Journal of Internal Medicine 2021; 289(6) doi: 10.1111/joim.13203
|
| 8 |
Huda M El-Sayed, Zeinab H El-Sayd, Tarek G Megahed, Mohammed M. Abd El-Wahab H El-Nabi. Fetuin-A. The Scientific Journal of Al-Azhar Medical Faculty, Girls 2019; 3(2) doi: 10.4103/sjamf.sjamf_53_19
|
| 9 |
Aloys Berg, H. David McCarthy. A soy-yoghurt-honey product as a therapeutic functional food: mode of action and narrative review. Heliyon 2022; 8(11) doi: 10.1016/j.heliyon.2022.e11011
|
| 10 |
Elke Roeb. MASLD – Prävention und ernährungsmedizinische
Behandlungsmöglichkeiten. Aktuelle Ernährungsmedizin 2023; 48(05) doi: 10.1055/a-2145-0934
|
| 11 |
Scott A. Willis, Sundus Malaikah, Siôn Parry, Stephen Bawden, Gaël Ennequin, Jack A. Sargeant, Thomas Yates, David R. Webb, Melanie J. Davies, David J. Stensel, Guruprasad P. Aithal, James A. King. The effect of acute and chronic exercise on hepatic lipid composition. Scandinavian Journal of Medicine & Science in Sports 2023; 33(5) doi: 10.1111/sms.14310
|
| 12 |
Vera Francisco, Maria Jesus Sanz, José T. Real, Patrice Marques, Maurizio Capuozzo, Djedjiga Ait Eldjoudi, Oreste Gualillo. Adipokines in Non-Alcoholic Fatty Liver Disease: Are We on the Road toward New Biomarkers and Therapeutic Targets?. Biology 2022; 11(8) doi: 10.3390/biology11081237
|
| 13 |
Johanna K. DiStefano. The Role of Choline, Soy Isoflavones, and Probiotics as Adjuvant Treatments in the Prevention and Management of NAFLD in Postmenopausal Women. Nutrients 2023; 15(12) doi: 10.3390/nu15122670
|
| 14 |
Asal Neshatbini Tehrani, Behzad Hatami, Bizhan Helli, Zahra Yari, Ghazal Daftari, Amin Salehpour, Mehdi Hedayati, Elmira Khalili, Seyed Ahmad Hosseini, Azita Hekmatdoost. The effect of soy isoflavones on non-alcoholic fatty liver disease and the level of fibroblast growth factor-21 and fetuin A. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-55747-6
|
| 15 |
Hao Qiang, Tianshu Xu, Peng Ma, Siyuan Zhang, Guanhua Du, Guifen Qiang, Tengfei Ji. A comprehensive review of meal replacement from dining table to sickbed: beyond biomedical potentials. Food Science and Human Wellness 2025; 14(3) doi: 10.26599/FSHW.2024.9250053
|
| 16 |
Peng Ma, Hao Ou, Zhongkan Sun, Yunbiao Lu, Mengdan Li, Liuxin Xu, Yan Liang, Jiawei Zheng, Yu Ou. IAVPGEVA: Orally Available DPP4-Targeting Soy Glycinin Derived Octapeptide with Therapeutic Potential in Nonalcoholic Steatohepatitis. Journal of Agricultural and Food Chemistry 2024; 72(13) doi: 10.1021/acs.jafc.3c08932
|
| 17 |
Eunbyul Cho, Sunwoo Kim, Soonkyu Kim, Ju Young Kim, Hwa Jung Kim, Yumi Go, Yu Jung Lee, Haesol Lee, Siye Gil, Sung Kwon Yoon, Keonho Chu. The Effect of Mobile Lifestyle Intervention Combined with High-Protein Meal Replacement on Liver Function in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Pilot Randomized Controlled Trial. Nutrients 2024; 16(14) doi: 10.3390/nu16142254
|
| 18 |
Pian Xiong, Yong-Fen Zhu. Soy diet for nonalcoholic fatty liver disease. Medicine 2021; 100(22) doi: 10.1097/MD.0000000000025817
|
| 19 |
E. Roeb, A. Canbay, H. Bantel, J. Bojunga, J. de Laffolie, M. Demir, U. W. Denzer, A. Geier, W. P. Hofmann, C. Hudert, T. Karlas, M. Krawczyk, T. Longerich, T. Luedde, M. Roden, J. Schattenberg, M. Sterneck, A. Tannapfel, P. Lorenz, F. Tacke. Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – AWMF-Registernummer: 021–025. Zeitschrift für Gastroenterologie 2022; 60(09) doi: 10.1055/a-1880-2283
|
| 20 |
Ingrid Rivera-Iñiguez, Arturo Panduro, Sonia Roman, Karina González-Aldaco. What do we know about nutrient-based strategies targeting molecular mechanisms associated with obesity-related fatty liver disease?. Annals of Hepatology 2023; 28(1) doi: 10.1016/j.aohep.2022.100874
|
| 21 |
Somaye Fatahi, Danial Fotros, Mohammad Hassan Sohouli, Koroush Vahidshahi, Pejman Rohani, Nathalia Sernizon Guimarães. Meal replacements on obesity and leptin: a systematic review and meta-analysis. Reviews in Endocrine and Metabolic Disorders 2025; 26(1) doi: 10.1007/s11154-024-09918-5
|
| 22 |
Elke Roeb. NAFLD – Prävention und ernährungsmedizinische
Behandlungsmöglichkeiten. Ernährung & Medizin 2022; 37(04) doi: 10.1055/a-1917-8335
|
| 23 |
. 2024; doi: 10.70675/7cd50e31z01f8z40f3z953az7777c5c68fac
|
| 24 |
Updated S2k Clinical Practice Guideline on Non-alcoholic Fatty Liver Disease (NAFLD) issued by the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS) – April 2022 – AWMF Registration No.: 021–025. Zeitschrift für Gastroenterologie 2022; 60(09) doi: 10.1055/a-1880-2388
|
| 25 |
Xiwei Liu, Yichao Ma, Ziyi Xu, Jun Wang, Mohamed Afifi. Protective Effect of Soybean Bioactive Compounds on Liver Disorders: A Bibliometric Analysis and Review. Journal of Food Biochemistry 2025; 2025(1) doi: 10.1155/jfbc/7436788
|
| 26 |
Pernilla Peterson, Lena Trinh, Sven Månsson. Quantitative 1H MRI and MRS of fatty acid composition. Magnetic Resonance in Medicine 2021; 85(1) doi: 10.1002/mrm.28471
|
| 27 |
Chao-Wu Xiao, Amy Hendry. Hypolipidemic Effects of Soy Protein and Isoflavones in the Prevention of Non-Alcoholic Fatty Liver Disease- A Review. Plant Foods for Human Nutrition 2022; 77(3) doi: 10.1007/s11130-022-00984-1
|
| 28 |
Hong Pan, Baocheng Liu, Xin Luo, Xinxin Shen, Jijia Sun, An Zhang. Non-alcoholic fatty liver disease risk prediction model and health management strategies for older Chinese adults: a cross-sectional study. Lipids in Health and Disease 2023; 22(1) doi: 10.1186/s12944-023-01966-1
|
| 29 |
Daisuke Yoshimaru. 6. Methods of Abdominal MR Spectroscopy and Future Prospects. Japanese Journal of Radiological Technology 2022; 78(2) doi: 10.6009/jjrt.780214
|
| 30 |
Joanna Betlejewska, Joanna Hubska, Zuzanna Roszkowska, Aleksandra Maciejczyk, Dominika Bachurska, Jan Domański, Maciej Miarka, Joanna Raszeja-Wyszomirska, Małgorzata Bobrowicz, Urszula Ambroziak. Endocrine Disorders and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review. Biomedicines 2025; 13(10) doi: 10.3390/biomedicines13102500
|
| 31 |
Fang-Zhou Ye, Wen-Yue Liu, Kenneth I. Zheng, Xiao-Yan Pan, Hong-Lei Ma, Xiao-Dong Wang, Yong-Ping Chen, Ming-Hua Zheng. Homeostatic model assessment of insulin resistance closely related to lobular inflammation in nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology 2020; 32(1) doi: 10.1097/MEG.0000000000001483
|
| 32 |
Lei Ai, Wei Luo, Peng Yuan, Ling Liu, Yue Zhou. Liver macrophages mediate effects of downhill running and caloric restriction on nonalcoholic fatty liver disease of high fat diet-fed mice. Life Sciences 2020; 256 doi: 10.1016/j.lfs.2020.117978
|
| 33 |
Scott A. Willis, Sundus Malaikah, Stephen J. Bawden, Aron P. Sherry, Jack A. Sargeant, Nicole A. Coull, Christopher R. Bradley, Alex Rowlands, Iyad Naim, Gaël Ennequin, Thomas Yates, Ghazala Waheed, Penny Gowland, David J. Stensel, David R. Webb, Melanie J. Davies, Guruprasad P. Aithal, James A. King. Greater hepatic lipid saturation is associated with impaired glycaemic regulation in men with metabolic dysfunction‐associated steatotic liver disease but is not altered by 6 weeks of exercise training. Diabetes, Obesity and Metabolism 2024; 26(9) doi: 10.1111/dom.15755
|
| 34 |
Daniel de Luis, David Primo, Olatz Izaola, Juan Jose Lopez. Effects of a Short-Term Meal Replacement Hypocaloric Diet in Subjects with Obesity and High Fatty Liver Index. Nutrients 2022; 14(24) doi: 10.3390/nu14245353
|
| 35 |
Zhendong Ma, Xinri Zhang, Yan Leng, Xingyu Chen. The liver–muscle axis in metabolic dysfunction-associated steatotic liver disease: a narrative review and conceptual framework for body-composition phenotyping. Frontiers in Medicine 2026; 13 doi: 10.3389/fmed.2026.1954630
|
| 36 |
Xiao-Ni Chai, Bing-Qian Zhou, Ni Ning, Ting Pan, Fan Xu, Si-Han He, Ni-Ni Chen, Mei Sun. Effects of lifestyle intervention on adults with metabolic associated fatty liver disease: A systematic review and meta-analysis. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1081096
|
| 37 |
Martin Buechert, Thomas Lange, Peter Deibert, Paul Urbain. In Vivo Fat Quantification: Monitoring Effects of a 6-Week Non-Energy-Restricted Ketogenic Diet in Healthy Adults Using MRI, ADP and BIA. Nutrients 2020; 12(1) doi: 10.3390/nu12010244
|
| 38 |
Dimitrios A. Koutoukidis, Constantinos Koshiaris, John A. Henry, Michaela Noreik, Elizabeth Morris, Indrani Manoharan, Kate Tudor, Emma Bodenham, Anna Dunnigan, Susan A. Jebb, Paul Aveyard. The effect of the magnitude of weight loss on non-alcoholic fatty liver disease: A systematic review and meta-analysis. Metabolism 2021; 115 doi: 10.1016/j.metabol.2020.154455
|
| 39 |
Christine L. Freer, Elena S. George, Sze-Yen Tan, Gavin Abbott, Robin M. Daly. Delivery of a telehealth supported home exercise program with dietary advice to increase plant-based protein intake in people with non-alcoholic fatty liver disease: a 12-week randomised controlled feasibility trial. British Journal of Nutrition 2024; doi: 10.1017/S0007114524000242
|